According to the amyloid cascade theory or the tau theory, early diagnosis of AD through measurement of amyloidβ (Aβ) or tau in the brain using positron-emission tomography (PET) or cerebrospinal fluid (CSF) assays has been studied [3, 5, 6]. The gene discussed is MAPT; the disease is Alzheimer disease.